OrbiMed’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-8,248
| Closed | -$1.03M | – | 156 |
|
|
2020
Q2 | $1.03M | Sell |
8,248
-16,076
| -66% | -$2M | 0.01% | 129 |
|
|
2020
Q1 | $4.69M | Buy |
+24,324
| New | +$4.69M | 0.08% | 106 |
|
|
2019
Q4 | – | Sell |
-9,203
| Closed | -$2.97M | – | 140 |
|
|
2019
Q3 | $2.97M | Sell |
9,203
-154
| -2% | -$49.7K | 0.06% | 99 |
|
|
2019
Q2 | $4.04M | Buy |
9,357
+553
| +6% | +$238K | 0.06% | 107 |
|
|
2019
Q1 | $4.98M | Buy |
+8,804
| New | +$4.98M | 0.08% | 102 |
|
|
2018
Q4 | – | Sell |
-6,566
| Closed | -$4.66M | – | 143 |
|
|
2018
Q3 | $4.66M | Buy |
+6,566
| New | +$4.66M | 0.06% | 128 |
|